Read + Share
Lee J, Kim M, Han HJ, Kim S, et al. Real-world survival outcomes of immune checkpoint inhibitor therapy after
standard treatment failure in EGFR-mutated NSCLC: A nationwide cohort study. Lung Cancer 2025;206:108682.
PMID: 40737730
|
 |
|
Lee J, Kim M, Han HJ, Kim S, et al. Real-world survival outcomes of immune checkpoint inhibitor therapy after
standard treatment failure in EGFR-mutated NSCLC: A nationwide cohort study. Lung Cancer 2025;206:108682.
PMID: 40737730
|
|
|
|